• Return to Headlines

Downgrade Alert for Bruker (BRKR)

By Shiri Gupta

Bruker (NASDAQ:BRKR) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $27.20 on volume of 1.9 million shares, above average daily volume of 1.1 million.

Over the past year, Bruker has traded in a range of $15.78 to $29.85 and closed yesterday at $27.20, 72% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.6%.

Bruker Corporation designs, manufactures, and markets proprietary life science systems based on spectrometry technology platforms. The Company also sells a range of field analytical systems for substance detection and pathogen identification. Bruker develops life science and advanced materials research tools based on X-ray technology.

Bruker (NASDAQ:BRKR) defies analysts with a current price ($27.20) 18.3% above its average consensus price target of $22.23. The stock should find resistance at its 50-day moving average (MA) of $28.13, as well as support at its 200-day MA of $22.60.

SmarTrend recommended that subscribers consider buying shares of Bruker on February 11th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $23.86. Since that recommendation, shares of Bruker have risen 15.9%. We continue to monitor BRKR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: analyst upgrades/downgrades bruker

Ticker(s): BRKR